Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Drug Therapy in the 1990s : What Can We Expect for Cystic Fibrosis?

Literature DB >> 28421554

Drug Therapy in the 1990s : What Can We Expect for Cystic Fibrosis?

Richard C Boucher¹.

Abstract

Entities: Disease

Year: 1992 PMID： 28421554 DOI： 10.2165/00003495-199243040-00001

Source DB: PubMed Journal: Drugs ISSN： 0012-6667 Impact factor: 9.546

× No keyword cloud information.

34 in total

1. Acute and long-term amiloride inhalation in cystic fibrosis lung disease. A rational approach to cystic fibrosis therapy.

Authors: E M App; M King; R Helfesrieder; D Köhler; H Matthys
Journal: Am Rev Respir Dis Date: 1990-03

2. Aerosol alpha 1-antitrypsin treatment for cystic fibrosis.

Authors: N G McElvaney; R C Hubbard; P Birrer; M S Chernick; D B Caplan; M M Frank; R G Crystal
Journal: Lancet Date: 1991-02-16 Impact factor: 79.321

3. Inhaled adenosine and guanosine on airway resistance in normal and asthmatic subjects.

Authors: M J Cushley; A E Tattersfield; S T Holgate
Journal: Br J Clin Pharmacol Date: 1983-02 Impact factor: 4.335

4. Chloride secretory response of cystic fibrosis human airway epithelia. Preservation of calcium but not protein kinase C- and A-dependent mechanisms.

Authors: R C Boucher; E H Cheng; A M Paradiso; M J Stutts; M R Knowles; H S Earp
Journal: J Clin Invest Date: 1989-11 Impact factor: 14.808

5. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.

Authors: J R Riordan; J M Rommens; B Kerem; N Alon; R Rozmahel; Z Grzelczak; J Zielenski; S Lok; N Plavsic; J L Chou
Journal: Science Date: 1989-09-08 Impact factor: 47.728

6. Expression of cystic fibrosis transmembrane conductance regulator corrects defective chloride channel regulation in cystic fibrosis airway epithelial cells.

Authors: D P Rich; M P Anderson; R J Gregory; S H Cheng; S Paul; D M Jefferson; J D McCann; K W Klinger; A E Smith; M J Welsh
Journal: Nature Date: 1990-09-27 Impact factor: 49.962

Drug Therapy in the 1990s : What Can We Expect for Cystic Fibrosis?

1. Acute and long-term amiloride inhalation in cystic fibrosis lung disease. A rational approach to cystic fibrosis therapy.

2. Aerosol alpha 1-antitrypsin treatment for cystic fibrosis.

3. Inhaled adenosine and guanosine on airway resistance in normal and asthmatic subjects.

4. Chloride secretory response of cystic fibrosis human airway epithelia. Preservation of calcium but not protein kinase C- and A-dependent mechanisms.

5. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.

6. Expression of cystic fibrosis transmembrane conductance regulator corrects defective chloride channel regulation in cystic fibrosis airway epithelial cells.

7. Expression of the cystic fibrosis gene in non-epithelial invertebrate cells produces a regulated anion conductance.

8. Regulation of Cl- channels in normal and cystic fibrosis airway epithelial cells by extracellular ATP.

9. Identification of the cystic fibrosis gene: chromosome walking and jumping.

10. Evidence for reduced Cl- and increased Na+ permeability in cystic fibrosis human primary cell cultures.

Review 1. Dornase alfa. A review of its pharmacological properties and therapeutic potential in cystic fibrosis.